There is a well-documented problem with enterprise AI right now. Companies try it, it works in the test environment, and then it quietly fails in production. MIT's Project NANDA research found that 95% of generative AI pilots delivered zero measurable business impact. A separate S&P Global survey found that 42% of companies abandoned most of their AI projects in 2025, up from 17% the year before.
The reason is rarely the AI's raw ability. It is reliability. In controlled demos, an AI tool looks impressive. In a live workflow, where a tax analyst, a lawyer, or a clinical researcher depends on the answer being correct, one confident wrong answer can cost more than the tool ever saved.
Pramaana Labs is making a direct bet on this gap. The San Francisco startup raised $27 million in seed funding, led by Khosla Ventures, with Accel, Nexus Venture Partners, Premji Invest, Boldcap, and Unbound also participating. The company targets fields where errors carry serious consequences: tax preparation, drug discovery, and law.
The approach has two layers. The first is a standard AI language model, which handles natural-language questions and reasoning. The second is a verification system built from formal logic, which checks whether the model's answer is actually consistent with the rules of the domain. If the tax code says something specific about a deduction, the system encodes that rule precisely and then checks whether the AI's answer follows it. Not approximately. Exactly.
This kind of mathematical rule-checking has a real track record outside of AI. France's CATALA project, developed at the national research institute Inria, spent years encoding French tax and benefits legislation into executable code. When researchers applied CATALA to the official French family benefits calculation, they found a bug in the government's own implementation. The rules, once written precisely, revealed an error that informal human processes had missed.
Pramaana is building on this tradition. The company's system translates domain rules, whether from a tax code, a drug interaction database, or a legal statute, into machine-checkable logic. Every answer the AI produces can then be traced back to a specific rule and either confirmed or flagged.
The team assembled to validate this work reflects the seriousness of the target markets. Former IRS commissioner Danny Werfel is advising on the tax system. Professors from IIT Delhi, IIT Madras, and UC Berkeley are overseeing the cybersecurity and drug discovery applications. These are not AI researchers brought in for polish. They are domain authorities who understand what correct looks like in their field.
For operators in regulated industries, the practical implication is this: the limiting factor in deploying AI is not whether the tool can do the task. It is whether you can stand behind the output. A wrong answer in a consumer app is an inconvenience. A wrong answer in a benefits calculation, a drug interaction check, or a tax position is a liability.
What Pramaana is selling, in essence, is accountability built into the architecture. Whether the approach scales across the full complexity of real-world legal and medical systems is the real question. Legal codes are not clean. They contradict themselves, evolve constantly, and carry interpretive disputes that courts have not resolved. Encoding them perfectly is a long project, not a launch feature.
But the direction is clear: the next competitive advantage in enterprise AI will not come from a smarter model. It will come from being the operator who can prove their AI got it right.